The authors present two cases of Ewing-like sarcoma of the humerus and femur of a 12-year-old boy and a 28-year-old male, respectively. Identical morphology in both tumors consisted of multiple solid nests with a mosaic collection of small, round, uniform cells with clear cytoplasm and no apparent nuclear atypia. A monotonous structural arrangement, including both rich vascularity of bordering septae and significant admixtures of eosinophil leucocytes, resulted in a final organoid "neuroendocrine-like" pattern. Immunohistochemistry revealed diffuse strong CD10, CD99 and CD138 positivity. Detailed molecular analysis in both tumors confirmed translocation t(20;22) resulting in an EWSR1-NFATc2 fusion gene. Additionally, this translocation was accompanied by amplification of the proximal part of the genes and surrounding areas. Clinically, both neoplasms behaved aggressively and they were primarily chemoresistant. Four years later, the patient with the lesion in the humerus developed a massive local recurrence with a disruption of osteosynthesis. The last follow-up disclosed suspicious metastatic deposits in the lung. The boy with the femoral tumor underwent a total femoral prosthesis and there are no signs of local or systemic recurrence after 11 months of follow-up. The authors discuss the taxonomic placement of these rare examples of Ewing-like sarcoma family in the light of new molecular discoveries.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ewing-like sarcoma
8
[where ewing
4
ewing sarcoma
4
sarcoma cases
4
cases unusual
4
unusual bone
4
bone tumors
4
tumors t2022ewsr1-nfatc2
4
t2022ewsr1-nfatc2 alteration]
4
alteration] authors
4

Similar Publications

Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling.

BMC Cancer

November 2024

Research Center, Boldrini Children's Hospital, Rua Marcia Mendes, 619, Cidade Universitaria, CEP 13083-884, Campinas, São Paulo, Brazil.

Pediatric sarcomas present heterogeneous morphology, genetics and clinical behavior posing a challenge for an accurate diagnosis. DNA methylation is an epigenetic modification that coordinates chromatin structure and regulates gene expression, determining cell type and function. DNA methylation-based tumor profiling classifier for sarcomas (known as sarcoma classifier) from the German Cancer Research Center (Deutsches Krebsforschungszentrum) was applied to 122 pediatric sarcomas referred to a reference pediatric oncology hospital.

View Article and Find Full Text PDF

The 5th edition of the World Health Organization (WHO) classification of soft tissue and bone has recognized three distinct groups among Ewing-like sarcomas, namely, CIC-rearranged sarcoma, sarcomas with genetic alterations, and round cell sarcomas with EWSR1:: non-ETS fusions. Sarcomas with genetic alterations are a distinct clinicopathological group of high-grade tumors, representing 5% of small round cell tumors. BCOR-ITD rearranged tumors commonly manifest as spindle cell sarcomas and many of them display low cellularity with monomorphous cell morphology and myxoid background resembling benign fibroblastic tumors.

View Article and Find Full Text PDF

[Undifferentiated small round cell sarcomas of bone and soft tissue].

Ann Pathol

November 2024

Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgique; O&N IV Herestraat 49, 3000 Leuven, Belgique.

In the 2020 5th edition of the World Health Organization classification of soft tissue and bone tumours a major reorganization of Undifferentiated Small Round Cell Sarcomas (USRCS) took place based on the underlying molecular features. The classification now recognizes Ewing sarcoma, round cell sarcoma with EWSR1-non-ETS fusions, CIC-rearranged sarcoma and sarcoma with BCOR alterations. The focus on these genetic alterations highlights the importance of molecular techniques in the diagnosis of these entities.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effectiveness of high-dose chemotherapy with autologous stem cell rescue (HDC-ASCR) in treating high-risk pediatric patients with Ewing sarcoma (ES), a rare cancer.
  • Over 17 years, researchers analyzed 20 patients who received this treatment, focusing on their disease response, complications, and survival rates.
  • Results showed promising outcomes with a 5-year overall survival rate of 54.5%, indicating HDC-ASCR could significantly benefit patients compared to traditional treatments.
View Article and Find Full Text PDF

Ewing sarcoma is a small round-cell sarcoma characterized by gene fusion involving EWSR1 (or another TET family protein like FUS) and an ETS family transcription factor. The estimated incidence of this rare bone tumor, which occurs most frequently in adolescents and young adults, is 0.3 per 100,000/year.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!